Abbott Laboratories - Laporan Laba Rugi (TTM)

Abbott Laboratories
CL ˙ SNSE ˙ US0028241000
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Abbott Laboratories menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 32,221 34,608 37,338 40,233 42,308 43,075 44,514 45,548 45,030 43,653 41,505 40,226 39,959 40,109 40,326 40,725 41,217 41,950 42,344 43,109
Change (%) 7.41 7.89 7.75 5.16 1.81 3.34 2.32 -1.14 -3.06 -4.92 -3.08 -0.66 0.38 0.54 0.99 1.21 1.78 0.94 1.81
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 13,928 15,003 15,975 17,160 18,116 18,080 18,666 19,151 18,858 19,083 18,427 17,977 17,953 17,919 18,051 18,171 18,264 18,644 18,636 18,831
Change (%) 7.72 6.48 7.42 5.57 -0.20 3.24 2.60 -1.53 1.19 -3.44 -2.44 -0.13 -0.19 0.74 0.66 0.51 2.08 -0.04 1.05
% of Revenue 43.23 43.35 42.78 42.65 42.82 41.97 41.93 42.05 41.88 43.72 44.40 44.69 44.93 44.68 44.76 44.62 44.31 44.44 44.01 43.68
Gross Operating Profit 18,293 19,605 21,363 23,073 24,192 24,995 25,848 26,397 26,172 24,570 23,078 22,249 22,006 22,190 22,275 22,554 22,953 23,306 23,708 24,278
Change (%) 7.17 8.97 8.00 4.85 3.32 3.41 2.12 -0.85 -6.12 -6.07 -3.59 -1.09 0.84 0.38 1.25 1.77 1.54 1.72 2.40
% of Revenue 56.77 56.65 57.22 57.35 57.18 58.03 58.07 57.95 58.12 56.28 55.60 55.31 55.07 55.32 55.24 55.38 55.69 55.56 55.99 56.32
SG&A 9,405 9,591 9,807 10,244 10,593 11,006 10,978 10,971 10,901 10,703 10,657 10,611 10,583 10,385 10,570 10,762 10,921 11,109 11,188 11,329
Change (%) 1.98 2.25 4.46 3.41 3.90 -0.25 -0.06 -0.64 -1.82 -0.43 -0.43 -0.26 -1.87 1.78 1.82 1.48 1.72 0.71 1.26
% of Revenue 29.19 27.71 26.27 25.46 25.04 25.55 24.66 24.09 24.21 24.52 25.68 26.38 26.48 25.89 26.21 26.43 26.50 26.48 26.42 26.28
R&D 2,289 2,420 2,441 2,531 2,623 2,738 2,781 2,811 2,921 2,741 2,698 2,729 2,619 2,619 2,649 2,632 2,673 2,823 2,842 2,862
Change (%) 5.72 0.87 3.69 3.63 4.38 1.57 1.08 3.91 -6.16 -1.57 1.15 -4.03 0.00 1.15 -0.64 1.56 5.61 0.67 0.70
% of Revenue 7.10 6.99 6.54 6.29 6.20 6.36 6.25 6.17 6.49 6.28 6.50 6.78 6.55 6.53 6.57 6.46 6.49 6.73 6.71 6.64
OpEx 27,729 29,146 30,303 31,966 33,373 33,871 34,475 34,986 34,711 34,540 33,774 33,300 33,136 32,889 33,217 33,485 33,752 34,454 34,492 34,797
Change (%) 5.11 3.97 5.49 4.40 1.49 1.78 1.48 -0.79 -0.49 -2.22 -1.40 -0.49 -0.75 1.00 0.81 0.80 2.08 0.11 0.88
% of Revenue 86.06 84.22 81.16 79.45 78.88 78.63 77.45 76.81 77.08 79.12 81.37 82.78 82.92 82.00 82.37 82.22 81.89 82.13 81.46 80.72
Operating Income 4,492 5,462 7,035 8,267 8,935 9,204 10,039 10,562 10,319 9,113 7,731 6,926 6,823 7,220 7,109 7,240 7,465 7,496 7,852 8,312
Change (%) 21.59 28.80 17.51 8.08 3.01 9.07 5.21 -2.30 -11.69 -15.17 -10.41 -1.49 5.82 -1.54 1.84 3.11 0.42 4.75 5.86
% of Revenue 13.94 15.78 18.84 20.55 21.12 21.37 22.55 23.19 22.92 20.88 18.63 17.22 17.08 18.00 17.63 17.78 18.11 17.87 18.54 19.28
Interest Expense -574 -546 -542 -542 -538 -533 -529 -527 -535 -558 -580 -607 -632 -637 -625 -606 -582 -559 -549 -530
Change (%) -4.88 -0.73 -0.00 -0.74 -0.93 -0.75 -0.38 1.52 4.30 3.94 4.66 4.12 0.79 -1.88 -3.04 -3.96 -3.95 -1.79 -3.46
% of Revenue -1.78 -1.58 -1.45 -1.35 -1.27 -1.24 -1.19 -1.16 -1.19 -1.28 -1.40 -1.51 -1.58 -1.59 -1.55 -1.49 -1.41 -1.33 -1.30 -1.23
Net Income 3,382 4,495 5,724 6,376 7,244 7,071 7,725 8,554 7,889 6,933 5,804 5,161 5,162 5,723 5,630 5,557 5,767 13,402 13,502 13,979
Change (%) 32.91 27.34 11.39 13.61 -2.39 9.25 10.73 -7.77 -12.12 -16.28 -11.08 0.02 10.87 -1.63 -1.30 3.78 132.39 0.75 3.53
% of Revenue 10.50 12.99 15.33 15.85 17.12 16.42 17.35 18.78 17.52 15.88 13.98 12.83 12.92 14.27 13.96 13.65 13.99 31.95 31.89 32.43

Source: Capital IQ

Other Listings
PE:ABT
AT:ABT
GB:0Q15
US:ABT US$ 132.94
MX:ABT
DE:ABL € 113.54
GB:ABLD
BG:ABL
CH:ABT
CL:ABTCL
KZ:ABT_KZ US$ 125.00
IT:1ABT € 113.42
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista